Phillip Mann, DO
NPI 1215425871 · Urology Physician · Saint Joseph, MO
Enrolled with Medicare as Practitioner - Urology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1215425871
- Entity type
- Individual
- Primary specialty
- Urology PhysicianAllopathic & Osteopathic Physicians
- Credential
- DO
- Sex
- Male
- Sole proprietor
- No
- License
- 2023025695 (MO)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Other Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
8 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
8,967 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Detection Test By Nucleic Acid for Organism, Amplified Probe Technique87798 | 1,280 | $34 |
| Chemical Analysis Using Spectrophotometry (light)84311 | 742 | $8 |
| Bilirubin Level, Total82247 | 384 | $5 |
| Urine Hemoglobin Level83069 | 384 | $4 |
| Body Fluid Ph Level83986 | 384 | $4 |
| Creatinine Level to Test for Kidney Function Or Muscle Injury82570 | 381 | $5 |
| Glucose (sugar) Level on Body Fluid82945 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 13 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Tamsulosin Hcl | 220 | 74 |
| Finasteride | 109 | 23 |
| Sulfamethoxazole/Trimethoprimbrand: Sulfamethoxazole-Trimethoprim | 99 | 68 |
| Ciprofloxacin Hcl | 48 | 41 |
| Estradiol | 47 | 38 |
| Nitrofurantoin Monohyd/M-Crystbrand: Nitrofurantoin Mono-Macro | 47 | 26 |
| Oxybutynin Chloridebrand: Oxybutynin Chloride Er |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$767 across 41 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2018-04-28
- Last updated
- 2025-05-28
- Certified
- 2025-05-28
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.